myeloid leukaemia
Further investigations revealed that knock-down of AGO2 by custom-made AGO2 siRNA in HEK-293 cells resulted in silencing of the expression of target genes vascular endothelial growth factor A and histone deacetylase 2, which are known to be involved in the development of myeloid leukaemia.
Further investigations revealed that knock-down of AGO2 by custom-made AGO2 siRNA in HEK-293 cells resulted in silencing of the expression of target genes vascular endothelial growth factor A and <span class="gene" id="21535412-5-196-217">histone deacetylase 2</span>, which are known to be involved in the development of <span class="disease" id="21535412-5-272-289">myeloid leukaemia</span>.